Partners
IUL launches iPeak+, the new lateral flow reader for rapid tests
IUL SA launches iPeak+, a new colorimetric off-the-shelf lateral flow reader designed to hold large cassettes. This...
ORYZON publishes vafidemstat first-in-human clinical trial manuscript in CNS Drugs journa...
Vafidemstat displayed good safety and tolerability in healthy young and elderly volunteers
ORYZON to participate in upcoming virtual international conferences in March and April
The company will attend to BIO-Europe Spring 2021, Kempen Life Sciences Conference and the 4 th SACHS Annual...
ORYZON announces successful pre-IND meeting with FDA for the clinical development of vafi...
Oryzon will consequently proceed to file an IND application PORTICO will be developed in several US and European sites
BIOLAN has launched its rapid serological test for the detection of antibodies against COV...
The Basque SME located in Zamudio has invested heavily to equip itself with the equipment that will allow it to scale up...
ORYZON presents vafidemstat 12-month clinical data from its Phase IIa clinical trials ETH...
Drug Developers Can Measure ADCC in Biologically Relevant Systems with New Promega Biolumi...
Promega PBMC ADCC Bioassay combines physiologically representative primary cells with reliable quantitative readout...
SIEMENS HEALTHINEERS Y IUL SA, una nueva alianza para combatir la COVID-19
The IUL’s reader, so-called iPeak®, capture, and process the image of the test guaranteeing the objectivity of the...
ORYZON announces FDA Orphan Drug Designation granted to iadademstat for treatment of Acute...
The compound is currently in Phase II Now has orphan designation in both U.S. and EU
Natac have just opened a process of international recruitment and selection of new profess...
Natac is looking for sales representatives